Details of the Drug Formulations

General Information of Drug (ID: DM3ED1A)

• Drug Name: Tavaborole Drug Info
• Synonyms: Kerydin; AN2690; AN-2690; AN-2690); SCH-900340; Topical antifungal (onychomycosis), Merck & Co; Trichophyton-targeting antifungal (onychomycosis), Merck & Co; Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Anacor Pharmaceuticals/Schering-Plough; Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Merck & Co/Anacor; Trichophyton-targeting antifungal (onychomycosis), Anacor Pharmaceuticals/Schering-Plough

Indication

Disease Entry	ICD 11	Status	REF
Onychomycosis	EE12.1	Approved	[1]

• Cross-matching ID:
  PubChem CID: 11499245
  ChEBI ID: CHEBI:77942
  CAS Number: 174671-46-6
  TTD ID: D05VGL
  ACDINA ID: D01462

Full List of Drug Formulations Containing This Drug

Tavaborole 5% solution

Company	Formulation ID	FDA Description
Anacor Pharms	F23298	Alcohol; Edetate Calcium Disodium; Propylene Glycol

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015